AAF Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,526
Closed -$227K 52
2025
Q1
$227K Buy
2,526
+217
+9% +$20.3K 0.12% 44
2024
Q4
$230K Buy
2,309
+179
+8% +$18.5K 0.12% 43
2024
Q3
$242K Buy
+2,130
New +$253K 0.12% 39
2024
Q1
Sell
-2,675
Closed -$292K 51
2023
Q4
$292K Sell
2,675
-23
-0.9% -$2.39K 0.17% 37
2023
Q3
$278K Sell
2,698
-82
-3% -$8.84K 0.18% 33
2023
Q2
$321K Buy
2,780
+80
+3% +$9.08K 0.2% 33
2023
Q1
$287K Buy
2,700
+460
+21% +$49.7K 0.19% 35
2022
Q4
$249K Buy
+2,240
New +$229K 0.18% 35

Other funds holding MRK

AAF Wealth Management's MRK Position: Q2 2025 in Review

AAF Wealth Management sold out of Merck (MRK) in Q2 2025, closing a stake of 2,526 shares — an estimated $227K sold.

AAF Wealth Management first reported a position in MRK in Q4 2022 and held it in 8 quarters. The position peaked at $321K in Q2 2023. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • AAF Wealth Management reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • AAF Wealth Management sold 2,526 Merck shares in Q2 2025, an estimated $227K.
  • AAF Wealth Management first reported a position in Merck in Q4 2022 and held it in 8 quarters.
  • AAF Wealth Management's Merck position peaked at $321K in Q2 2023.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on AAF Wealth Management's 13F filing for Q2 2025, filed 5 Aug 2025.